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OBJECTIVE: Prevention is the best treatment for cerebrovascular disease, which is why early diagnosis and the
immediate treatment of carotid stenosis contribute significantly to reducing the incidence of stroke. Given its silent
nature, 80% of stroke cases occur in asymptomatic individuals, emphasizing the importance of screening individuals
with carotid stenosis and identifying high-risk groups for the disease. The aim of this study was to determine the
prevalence and the most frequent risk factors for carotid stenosis.
METHODS: A transversal study was conducted in the form of a stroke prevention campaign held on three non-
consecutive Saturdays. During the sessions, carotid stenosis diagnostic procedures were performed for 500
individuals aged 60 years or older who had systemic arterial hypertension and/or diabetes mellitus and/or coronary
heart disease and/or a family history of stroke.
RESULTS: The prevalence of carotid stenosis in the population studied was 7.4%, and the most frequent risk factors
identified were mean age of 70 years, carotid bruit, peripheral obstructive arterial disease, coronary insufficiency
and smoking. Independent predictive factors of carotid stenosis include the presence of carotid bruit or peripheral
obstructive heart disease and/or coronary insufficiency.
CONCLUSIONS: The population with peripheral obstructive heart disease and carotid bruit should undergo routine
screening for carotid stenosis.
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INTRODUCTION
In 2004, the Atlas of Heart Disease and Stroke published
by the World Health Organization registered a total of
129,172 deaths as a result of stroke in Brazil (1). The same
publication reported that approximately 15 million people
suffer from stroke annually worldwide, and 5.5 million of
them die as a result of the disease.
Ischemic stroke accounts for 67% to 83% of all strokes (2). It
can be caused by carotid artery disease, cardiac arrhythmia
and arterial hypertension (3). Extracranial cerebrovascular
disease stems from atherosclerotic lesions located predomi-
nantly in the carotid bifurcation and are responsible for up to
75% of ischemic stroke events (2). These lesions can cause
cerebral ischemia via the embolization of atheromatous
plaques, the formation of thrombi or arterial occlusion.
However, this type of lesion is easily diagnosed with non-
invasive methods and can be managed with effective
therapeutic options (4).
Barnett et al. (5) estimated that approximately two million
North Americans and Europeans have treatable asympto-
matic carotid artery stenosis. Roederer et al. (6) estimated
the risk of stroke or total carotid occlusion at 46% per year in
patients with asymptomatic carotid stenosis greater than or
equal to 80%. According to Chambers et al. (7), individuals
with carotid stenosis greater than or equal to 75% have a
26% risk of developing stroke in three years.
Given its silent nature, 80% of stroke cases occur in
asymptomatic individuals (8), hence the importance of
screening individuals with carotid stenosis and identifying
groups at high risk for the disease. Moreover, the annual
progression of moderate to severe stenosis is 14% (9).
Few studies have focused on determining the prevalence
of carotid stenosis in the general population because
the operational costs of routine screening are high.
Nevertheless, the estimated prevalence of carotid stenosis
greater than or equal to 50% in the general population ranges
from 2 to 8%, and the estimated prevalence of stenosis greater
than or equal to 80% ranges from 1 to 2% (10). Therefore,
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studies have attempted to identify a high-risk population that
would benefit from the early diagnosis of carotid stenosis.
According to Yin and Carpenter (11), screening asympto-
matic individuals is only cost-effective in populations
presenting with the following characteristics: carotid steno-
sis prevalence greater than 4.5%; echo Doppler specificity
greater than 91%; stroke incidence during clinical treatment
greater than 3.3%; reduction in stroke risk greater than 37%;
and occurrence of stroke associated with carotid endarter-
ectomy consistent with the rates published by NASCET and
ACAS. Furthermore, the operational cost per exam must be
less than US$300.
According to a committee of the American Society of
Neuroimaging (12), cost-effective screening lowers the
stroke risk when the carotid stenosis prevalence is between
5% and 20%, and screening does not reduce stroke risk and
is not cost-effective when the carotid stenosis prevalence is
lower than 5%.
In Brazil, no screening studies in this patient group have
been conducted for the general population or a selected
population. This lack of studies informed the rationale for
this study, which sought to contribute to a deeper under-
standing of the role of carotid stenosis screening in
populations at risk for atherosclerosis, to determine the
prevalence of the disease and to characterize the population
at high risk of developing the disease.
METHODS
This study was previously approved by the Research
Ethics Committee under Project No. 469/07.
The Department of Vascular and Endovascular Surgery
conducted a transverse study in the form of a stroke
prevention campaign in May and June 2004. The campaign
was publicized through pamphlets, flyers displayed on
newsstands and at pharmacies and bakeries and via radio
broadcasts and advertisements in local newspapers in
downtown Sa˜o Paulo city.
The campaign was run on three non-consecutive
Saturdays. Carotid stenosis diagnosis sessions were offered
to interested individuals who were aged 60 years or older
and who were diagnosed with one of the following
conditions: systemic arterial hypertension, diabetes melli-
tus, coronary heart disease or familial history of stroke.
These factors constituted the study’s inclusion criteria.
Interested individuals were asked to call the telephone
number provided and to schedule a day and time for an
interview and exam.
A total of 632 interviews were scheduled by phone. Of
these, 582 individuals participated in the scheduled inter-
views. Eighty-two volunteers did not meet the campaign
criteria and were excluded from the study. The final sample
consisted of 500 individuals.
The interviews were conducted by eight physicians from
the Department of Vascular and Endovascular Surgery, who
administered a predetermined questionnaire addressing the
health history and familial morbid antecedents of each
volunteer. A physical exam was then performed to check for
carotid bruit, palpate the pulses of the extremities and take
blood pressure readings.
After the interview and physical exam, the volunteers were
referred for an ultrasonography exam with Doppler (Prologic
7 device by GE - Waukesha, USA and SD800 device by
Phillips - Amsterdam, Netherlands) to detect occult carotid
stenosis, according to the model proposed by Jacobowitz
et al. (2,13). This scan consists of a modified ultrasonographic
exam, which has been regularly validated and compared
with angiography and angioresonance as part of an accred-
itation by the Intersocietal Commission for the Accreditation
of Vascular Laboratories (ICAVL). The test consists of an
examination of the distal common carotid artery and the bulb
and proximal segments of the internal and external carotid
arteries, including the determination of peak systolic velo-
cities in the internal carotid artery. A velocity greater than or
equal to 120 cm/s is considered to indicate the presence of
.50% stenosis. In addition to this criterion, the common and
internal carotid arteries underwent a morphological analysis
that classified them as normal, narrowed, less than 50%
stenosis, or greater than 50% stenosis.
Ultrasound exams were conducted by three radiologists
specializing in vascular ultrasonography. All positive
results were subsequently confirmed by a second examiner.
The volunteers were split into two groups based on the
ultrasound exam findings:
N Positive: Internal carotid artery stenosis $50%
N Negative: Internal carotid artery stenosis ,50%
The groups were then analyzed for the following
variables:
N Age
N Gender
N Race
N Arterial hypertension (SAH): Systolic arterial pressure
$140 mmHg and/or diastolic $90 mmHg (14) or
chronic use of anti-hypertensive medication;
N Diabetes mellitus (DM) with a fasting glucose exam
$126 mg/dL (15) or the use of oral hypoglycemics or
insulin;
N Dyslipidemia: Cholesterol levels $200 mg/dL or LDL
levels $130 mg/dL or triglyceride levels $150 mg/dL
(16) or the use of statins or fibrates;
N Peripheral obstructive arterial disease (POAD): The
absence of pulses in the extremities, confirmed by a
second examiner;
N Coronary insufficiency (CI): The presence of stable or
unstable angina, history of myocardial infarction, myo-
cardial revascularization or coronary angioplasty;
N Other cardiopathies, such as arrhythmias, valvulopa-
thies, congestive cardiac insufficiency or the use of a
pacemaker or an internal cardioverter defibrillator;
N Smoking: Current smokers who have smoked at least 100
cigarettes throughout their lifetime (17);
N Signs and symptoms of a cerebral ischemic event:
Asymptomatic, syncope, transient ischemic attack or
stroke (amaurosis fugax, aphasia or dysphasia and
motor deficit);
N Family history of stroke in first-degree relatives;
N Presence of carotid bruit based on auscultation of the
cervical region at the medial border of the sternocleido-
mastoid muscle with a stethoscope.
A 5% level of significance was adopted. Values expressed
in frequencies were compared using the chi-squared test
and its variations (Fisher’s exact test and a generalization of
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Fisher’s exact test for tables with low frequencies). Special
attention was given to the variable "carotid bruit", which
was treated as a dependent variable.
The Student’s t test, controlled by Levene’s test, was used
to compare continuous values.
A logistic regression analysis was used to determine the
relationship between the study variables and exam results.
The regression model was tested by selecting the variables
that were significant at a level of 10% in a univariate
analysis (p,0.100).
The data were tabulated and analyzed using the SAS 9.1
software program.
RESULTS
The characteristics of the study sample are shown in
Table 1.
Ultrasound examinations revealed positive results (i.e.,
$50% carotid stenosis) in 37 individuals, representing 7.4%
of the population assessed.
When positive and negative carotid stenosis results
were compared by subjects’ ages, the mean age of the posi-
tive group (70.4¡6.8 years) was statistically significantly
higher than that of the negative group (67.5¡6.3; p = 0.01).
However, no statistical differences in gender or race were
detected between the carotid stenosis-positive and negative
groups.
Table 2 presents a comparison of the carotid stenosis-
positive and negative groups in terms of the presence of risk
factors for atherosclerosis. The results indicate that only the
variables PAOD, Smoking and CI are individual risk factors
for internal carotid artery stenosis .50%.
Regarding cerebral ischemia symptoms, no statistically
significant differences were observed between the carotid
stenosis-positive and negative groups in terms of reported
syncope, motor sequelae or amaurosis fugax.
Ten individuals (2%) tested positive for carotid bruit
(Table 3). Carotid bruit was identified in 50% of the subjects
in the positive group, while only 7.1% of the individuals
without carotid bruit had significant stenosis of the carotid
artery.
No statistically significant association was observed
between the sum of the risk factors and an increased
prevalence of carotid stenosis (Table 4).
Based on the model containing the six most significant
variables that were identified during the univariate analysis,
we concluded that the presences of bruit and POAD are
predictors of carotid stenosis (p,0.05).
The presence of cardiac bruit increased the probability of
a positive exam result 12-fold (OR = 12.6) and that POAD
increased the likelihood of a positive result 3-fold (OR = 3.7)
compared to the chance of positivity when these factors
were absent (Table 5).
The variable ‘‘coronary insufficiency’’ had a descriptive
level of approximately 5% (p = 0.045). Taking this level as
significant, we can conclude that, on average, the likelihood
of a positive ultrasound result is doubled in the presence of
angioplasty, coronary artery bypass or angina compared to
the absence of these conditions (OR = 2.3).
Table 5 shows the most frequent variables associated with
a positive ultrasound result.
DISCUSSION
The diagnostic method employed in this study was
ultrasonography with Doppler using a modified version of
the approach described by Jacobowitz et al. (8). The cut-off
value adopted was close to the value recommended by
Carsen III et al. (18), who observed optimal sensitivity
(91%), specificity (95%), positive predictive value (89%) and
negative predictive value (96%) with a cut-off of 115 cm/s
in screening exams that took an average of 3.2 minutes to
perform per patient.
In this population-based study, the prevalence of .50%
stenosis of the internal carotid artery was 7.4%.
The prevalence of significant asymptomatic carotid
stenosis ($50%) varies. Prevalences between 4 and 8% were
found in the general population, with advanced age being
the only independent predictor of significant asymptomatic
carotid stenosis (8,9). In contrast, the values reported by
Qureshi et al. (12) ranged from 7% to 35%, depending on the
isolated or associated presence of such risk factors as
age over 65 years, smoking, coronary insufficiency, and
hypercholesterolemia.
In this study, no statistical significances were identified
for the variables gender, race, SAH, DM, dyslipidemia,
cardiopathies, familial history of stroke, or cerebral ischemia
symptoms. Similarly, the sum of the risk factors did not
predict carotid stenosis.
In terms of gender, the literature only reports a stati-
stically significant difference when analyzing specific sub-
groups, such as candidates for myocardial revascularization
(greater risk among women) (19) or individuals with POAD
Table 1 - Characterization of a sample of 500 participants
in the Stroke Prevention Campaign who underwent
carotid stenosis screening.
Total
Age (years)
Mean¡S.D. 67.8¡6.4
Median 66.0
Minimum-maximum 60–89
Gender - n (%)
Female 279 (55.8%)
Male 221 (44.2%)
Race - n (%)
White 413 (82.6%)
Black 60 (12.0%)
Yellow 27 (5.4%)
Signs and symptoms of stroke - n (%)
Asymptomatic 255 (51.0%)
Visual symptoms 57 (11.4%)
Syncope 53 (10.6%)
Sequelae 18 (3.6%)
Variables - n (%)
SAH 364 (72.8%)
Dyslipidemia 250 (50.0%)
Family history of stroke 215 (43.0%)
Smoking 182 (36.4%)
CI (angina, angioplasty or coronary artery
bypass)
122 (24.4%)
DM 116 (23.2%)
PAOD 107 (21.4%)
Cardiopathy 90 (18.0%)
Bruit 10 (2.0%)
Total 500 (100.0%)
SAH: Arterial hypertension; CI: Coronary insufficiency; DM: Diabetes
mellitus; PAOD: Peripheral obstructive arterial disease.
CLINICS 2012;67(8):865-870 Carotid stenosis: high risk-population
Park JH et al.
867
(greater risk among men) (20). No reports were found that
described differences related to race (2,8,10).
The percentage of patients with SAH was significantly
higher in the group that tested positive for .50% carotid
stenosis, although SAH was not an independent predictor.
This finding contrasts with some authors’ results (2,8)
but corroborates the observations of Qureshi et al. (12),
indicating that isolated SAH should not be used as a marker
for screening asymptomatic carotid stenosis.
The presence of DM was not significantly correlated with
carotid stenosis. This finding is consistent with the majority
of previous scientific studies, although DM is regarded as a
risk factor in the pathogenesis of atherosclerosis (9,10,21).
The presence of dyslipidemia did not predict carotid
stenosis in this study, corroborating the results of most
studies in the literature (2,8,9,20,22).
Univariate analysis showed that of the variables studied,
advanced age, smoking, POAD, and CI were predictors of
carotid stenosis.
The direct relationship between age and carotid stenosis
risk has been confirmed by several previous studies
(9,10,21,23,24), and our results corroborated this finding.
Smoking is considered one of the most important risk
factors in the genesis of atherosclerosis. However, there is a
lack of consensus in the literature regarding the predictive
value of the association between smoking and carotid
stenosis. Some authors have confirmed this link (2,9,10),
while others have failed to observe a statistically significant
association. In this study, smoking was reported in 51% of
the carotid stenosis-positive group. While the univariate
analysis revealed that smoking was a predictive factor for
carotid stenosis, the association was not significant in the
subsequent multivariate analysis.
Consistent with our findings, several studies have
identified both POAD (20,24,25) and CI (2,10,12,20) as
independent predictors for significant asymptomatic carotid
stenosis.
In male populations with POAD, a carotid stenosis
prevalence of 18% was detected in young adults (20), and
a 20% prevalence was identified in elderly adults (25). CI
was found to be a predictive factor for .50% carotid
stenosis in both of these groups, especially the younger
group (19,25). In a Chinese population, this prevalence
Table 2 - Comparison of variables considered risk factors for atherosclerosis between the groups that were positive and
negative for carotid stenosis on ultrasound.
Presence of risk factors for atherosclerosis Ultrasound p-value
Negative Positive
SAH p= 0.054
No 130 (96.3%) 5 (3.7%)
Yes 333 (91.2%) 32 (8.8%)
DM p= 0.147
No 352 (91.7%) 32 (8.3%)
Yes 111 (95.7%) 5 (4.3%)
Dyslipidemia p= 0.393
No 229 (91.6%) 21 (8.4%)
Yes 234 (93.6%) 16 (6.4%)
PAOD p,0.001*
No 369 (94.4%) 22 (5.6%)
Yes 91 (83.5%) 18 (16.5%)
CI p= 0.002*
No 358 (94.7%) 20 (5.3%)
Yes 105 (86.1%) 17 (13.9%)
Cardiopathy p= 0.237
No 377 (92.0%) 33 (8.0%)
Yes 86 (95.6%) 4 (4.4%)
Smoking p= 0.020*
No 300 (94.3%) 18 (5.7%)
Yes 163 (89.6%) 19 (10.4%)
Family history of stroke p= 0.315
No 261 (91.6%) 24 (8.4%)
Yes 202 (94.0%) 13 (6.0%)
Table 3 - Comparison of the presence of carotid bruit and
carotid stenosis findings on ultrasound.
Ultrasound Total p-value
Negative Positive
Bruit - n (%) p,0.001
No 455 (92.9%) 35 (7.1%) 490 (100.0%)
Yes 5 (50.0%) 5 (50.0%) 10 (100.0%)
Total patients 460 (92.0%) 40 (8.0%) 500 (100.0%)
p-value: Fisher’s exact test.
Table 4 - Association between the number of risk factors
and the presence of carotid stenosis on ultrasound.
Ultrasound Total p-value
Negative Positive
No. of risk factors – n
(%)
p= 0.064
1 78 (97.5%) 2 (2.5%) 80 (100.0%)
2 122 (94.6%) 7 (5.4%) 129 (100.0%)
3 or more 263 (90.4%) 28 (9.6%) 291 (100.0%)
Total patients 463 (92.6%) 37 (7.4%) 500 (100.0%)
p-value: Fisher’s exact test.
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reached 24.7%, and risk factors included advanced age,
carotid bruit and smoking, with a particular emphasis on
the number of cigarettes smoked per day (24).
A study involving 168 patients with atherosclerotic
aortoiliac disease identified a 28% prevalence of significant
carotid stenosis; advanced age and the presence of carotid
bruit were predictors of more severe stenoses in this
population (26).
The close relationship between carotid stenosis and
coronary heart disease has been recognized, as the diseases
share the same risk factors and pathogenic mechanisms. The
literature indicates that the prevalence of CI in patients with
extracranial cerebral disease ranges from 40% to 60%, and
the carotid disease rate in candidates for myocardial
revascularization ranges from 2 to 27%, based on a review
of 12 studies published between 1983 and 1996 (27). The
13.9% prevalence of $50% carotid stenosis among indivi-
duals with CI in this study is consistent with the rate
reported in the literature.
Several studies have reported a positive relationship
between cervical bruit and carotid stenosis (28,29).
According to the ACAS, ipsilateral bruit was detected in
75% of individuals with $60% carotid stenosis, suggesting
that 80% of patients with significant carotid disease had
carotid bruit.
Some screening programs have identified carotid bruit as
a strong predictor of carotid stenosis, particularly among
men with PAOD (24,25). Our results found that 50% of
individuals with $50% carotid stenosis had carotid bruit; its
sensitivity as a predictor was 50%. Lavenson Jr. et al. (30)
screened 176 individuals to validate a stroke prevention
protocol and found a carotid bruit rate similar to that
identified in this study. Despite its low sensitivity, the
presence of carotid bruit proved highly specific for the
occurrence of carotid stenosis, yielding a negative predictive
value of 0.99.
Two other studies also aimed to determine the population
that would benefit most from carotid stenosis screening. The
first of these studies (8) included 394 individuals and found
a carotid stenosis prevalence ranging between 1.8% (no risk
factors) and 66.7% (four associated risk factors). Heart
disease and arterial hypertension have been determined as
predictors of significant asymptomatic carotid stenosis.
However, this study failed to confirm this association
between the number of risk factors and an increased
prevalence of carotid stenosis.
In the second study (2), 610 individuals were screened. A
10.8 % prevalence of carotid stenosis was found, indicating
a strong correlation with CI. Our screening study revealed a
lower prevalence (7.4%), but CI was also found to be an
independent predictor of .50% carotid stenosis.
Among the studied risk factors for atherosclerotic disease,
the presence of carotid bruit, PAOD, advanced age, CI and
smoking were significantly correlated with a diagnosis of
.50% carotid stenosis in univariate analyses. However, a
multivariate logistic regression analysis only identified
correlations between carotid stenosis and carotid bruit,
PAOD and CI, which were determined to be significant
independent risk factors for carotid stenosis. The results of
relative risk calculations confirmed the association between
stenosis and carotid bruit.
Conclusive studies to determine the cost-benefit of this
screening are needed. Although the prevalence of asympto-
matic carotid stenosis was significant in the population
studied (7.4%) and was consistent with the recommenda-
tions by Yin and Carpenter (11), the cost of each confirmed
diagnosis in this study was US$ 358.00. The acceptable
recommended cost is approximately US$ 300.00 per positive
diagnosis.
The adoption of more specific criteria, such as those
employed in this study, combined with the introduction of
portable ultrasonography equipment may increase the cost-
effectiveness of carotid stenosis screening and may increase
physicians’ awareness of the importance of identifying
high-risk individuals for stroke prevention.
The prevalence of carotid stenosis in the studied popula-
tion was 7.4%, and the most frequent risk factors identified
were a mean age of 70 years, carotid bruit, peripheral
obstructive arterial disease, coronary insufficiency and
smoking.
Independent predictive factors of carotid stenosis include
the presence of carotid bruit or peripheral obstructive heart
disease and/or coronary insufficiency. Populations that
meet these criteria should undergo routine screening for
carotid stenosis.
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